NCT00207948View on ClinicalTrials.gov

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

TerminatedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

May 31, 2009

Study Completion Date

July 31, 2009

Conditions
HIV Infections
Interventions
DRUG

Dose adjustment of Kaletra

Adjust the dose by up to +50% of reccomended dosa off the drug to meet target therapeutic concentrations

Trial Locations (1)

20010

Children's National Medical Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Children's National Research Institute

OTHER